Market Place
Sourcing Support
Organogenesis Expands Manufacturing Capacity For Future Growth
22 Nov 2024 //
GLOBENEWSWIRE
Organogenesis Commends Final LCDs
15 Nov 2024 //
GLOBENEWSWIRE
Organogenesis Announces $130M Private Placement Offering
12 Nov 2024 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. Reports Q3 2024 Financial Results
12 Nov 2024 //
GLOBENEWSWIRE
Organogenesis Reports Positive Data for ReNu in Knee Osteoarthritis
11 Nov 2024 //
GLOBENEWSWIRE
Organogenesis Holdings To Report Q3 2024 Financial Results
16 Oct 2024 //
GLOBENEWSWIRE
Organogenesis Publishes Trial Results for NuShield in Diabetic Foot Ulcers
01 Oct 2024 //
GLOBENEWSWIRE
Organogenesis To Join Investor Conferences In September
04 Sep 2024 //
GLOBENEWSWIRE
Organogenesis Shares ReNu® Program Update
08 Aug 2024 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
Organogenesis To Report Q2 2024 Results On August 8th
15 Jul 2024 //
GLOBENEWSWIRE
Organogenesis To Participate In Truist MedTech Conference
06 Jun 2024 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
09 May 2024 //
GLOBENEWSWIRE
Organogenesis: ReNu® Meets Phase 3 Endpoint In Knee Osteoarthritis
02 May 2024 //
GLOBENEWSWIRE
Organogenesis to Report Q1 2024 Results on May 9, 2024
16 Apr 2024 //
GLOBENEWSWIRE
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
03 Apr 2024 //
GLOBENEWSWIRE
Organogenesis to Report Third Quarter of Fiscal Year 2023 Financial Results
05 Oct 2023 //
GLOBENEWSWIRE
Organogenesis Applauds Withdrawal of Local Coverage Determinations
28 Sep 2023 //
GLOBENEWSWIRE
Organogenesis to Participate in the Morgan Stanley 21st Annual Global Conference
06 Sep 2023 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Organogenesis to Report Second Quarter of Fiscal Year 2023 Financial Results
10 Jul 2023 //
GLOBENEWSWIRE
Organogenesisto Report First Quarter of Fiscal Year 2023 Financial Results
10 Apr 2023 //
GLOBENEWSWIRE
Organogenesis Applauds Findings from the Office of Inspector General
27 Mar 2023 //
GLOBENEWSWIRE
Organogenesis to Report Fourth Quarter Financial Results on March 1, 2023
09 Feb 2023 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results
09 Nov 2022 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022
26 Sep 2022 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual GHC
07 Sep 2022 //
GLOBENEWSWIRE
Organogenesis Receives FDA Clearance for PuraPly Surgical Solution
15 Aug 2022 //
GLOBENEWSWIRE
Organogenesis to Report Q2 of Fiscal Year 2022 Financial Results
30 Jun 2022 //
GLOBENEWSWIRE
Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
Organogenesis Appoints Michele Korfin, Gilberto Quintero to Board of Directors
05 May 2022 //
GLOBENEWSWIRE
Organogenesis Shows Latest Advanced Wound Care Innovations and Research at SAWC
05 Apr 2022 //
GLOBENEWSWIRE
Organogenesis to Report First Quarter of Fiscal Year 2022 Financial Results
05 Apr 2022 //
GLOBENEWSWIRE
Organogenesis Named One of 50 Highest Growth Companies in Massachusetts
17 Mar 2022 //
GLOBENEWSWIRE
Organogenesis Holdings Reports Q4 and Fiscal Year 2021 Financial Results
01 Mar 2022 //
GLOBENEWSWIRE
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
17 Feb 2022 //
GLOBENEWSWIRE
Organogenesis to Participate in Upcoming Investor Conferences in February
11 Feb 2022 //
GLOBENEWSWIRE
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research
27 Oct 2021 //
GLOBENEWSWIRE
Organogenesis falls on anonymous short report
12 Oct 2021 //
SEEKINGALPHA
Organogenesis to Report Q2 of Fiscal Year 2021 Financial Results
02 Jul 2021 //
GLOBENEWSWIRE
